CS Capital logo

CS Capital

Asia, Shanghai, China, Shanghai

Description

CS Capital is an investment firm that offers investment management service.

Investor Profile

CS Capital has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Private Equity, Series A rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (60%)
  • Private Equity (20%)
  • Series A (20%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Genetics
  • Manufacturing
  • Pharmaceutical
  • Therapeutics
  • Outsourcing
  • Service Industry
  • Fleet Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CS Capital frequently co-invest with?

China Merchants Group
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Binfu Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
October Capital
North America, Missouri, United States, Kansas City
Co-Investments: 2
ALAN AMC
Asia, Beijing, China, Beijing
Co-Investments: 2
Co-Stone Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
China Merchants Health
Asia, Hunan, China, Nanshan
Co-Investments: 1
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Gaorong Capital
Asia, Beijing, China, Wangjing
Co-Investments: 2
China Merchants Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by CS Capital?

Changfeng Bio is the developer of biomedical material technologies, focused on addressing clinical challenges across medical disciplines.

BiopharmaBiotechnology
SeedSep 12, 2025
Inari Medical

Shanghai, Shanghai, China

Inari Medical focuses on providing full-process solutions for bone metabolism management throughout the life cycle.

Medical
SeedAug 1, 2025
Amount Raised: $1,387,193
Lingmo Medical

Hangzhou, Zhejiang, China

Lingmo Medical is a company that provides department-level flexible endoscopic solutions.

Health CareHospitalMedicalWellness
Series AApr 7, 2025
Biointron

Shanghai, Shanghai, China

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.

BiotechnologyHealth CareMedical
Series BAug 31, 2022
Amount Raised: $72,564,728
Baiying Bio

Beijing, Beijing, China

Baiying Bio is a research and development outsourcing service provider.

BiotechnologyOutsourcingService Industry
Series BAug 31, 2022
Amount Raised: $72,564,728
Porton Advanced Solutions

Suzhou, Jiangsu, China

Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

BiotechnologyGeneticsManufacturingPharmaceuticalTherapeutics
Series BAug 21, 2022
Amount Raised: $80,000,000
G7

Haidian, Beijing, China

G7 is a fleet management service provider in China that offers IoT/AI services to over 800,000 vehicles.

Fleet ManagementInformation TechnologyInternet of ThingsLogisticsTransportation
Private EquityFeb 15, 2022
Amount Raised: $200,000,000